title: Effect of interferon alfa-2b and ribavirin treatment on hepatitis C-associated cryoglobulinemia and rheumatoid factor: comment on the article by Vassilopoulos and Calabrese.
authors.forename: Swati
authors.initials: S
authors.lastname: Medhekar
authors.forename: Angella
authors.initials: A
authors.lastname: Nutt
authors.forename: J P
authors.initials: JP
authors.lastname: Raufman
authors.forename: Hugo E
authors.initials: HE
authors.lastname: Jasin
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000097:blood / Q000821:virology*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012217:Rheumatoid Factor / Q000378:metabolism; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin; D012217:Rheumatoid Factor